Decision aid for managing suspicious thyroid nodules
Part of Cancer, Hormones & metabolism clinical trials.
This trial studies a decision-support tool to help people make choices about care for thyroid nodules that look indeterminate to cancer on biopsy. It may help you understand options and decide next steps more confidently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a thyroid biopsy result that is indeterminate or cancer-like (Bethesda category III, IV, V, or VI)
- Your thyroid nodule measures 2 centimeters or smaller
- You have never had thyroid surgery
- You do not have a past history of thyroid cancer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how doctors talk with patients who have a thyroid nodule that may need a biopsy. It aims to improve communication and help patients feel more involved in their care.
This trial is for people with certain types of thyroid nodules that are considered low risk. Instead of surgery right away, the study will follow the nodules over time to see if they change. The goal is to find out if it's safe to avoid immediate surgery.
This study looks at ways to better estimate the cancer risk of thyroid nodules that are “unclear” on standard testing. It uses information from your clinical history, ultrasound findings, and additional lab/genetic-type features to help sort which nodules are more likely to be cancer.
This trial tests whether taking myo-inositol and selenium supplements can help reduce the risk of thyroid cancer in people with thyroid nodules that are considered 'indeterminate' (TIR3a). The goal is to see if these supplements can prevent the nodules from becoming cancerous.
This study is testing whether it is safe to simply monitor (watch closely) a small thyroid nodule that has a certain biopsy result (Bethesda IV) instead of removing it right away. You would not receive a treatment, but would have regular checkups and ultrasounds to see if the nodule changes.
This trial studies radiofrequency ablation, a procedure that shrinks a thyroid nodule, for thyroid nodules that are unclear on biopsy but have a reassuring “molecular” test. If you have a Bethesda III nodule that tests benign on specific genetic tests, you may be a good candidate to see if this approach helps safely.
Hear when a new Thyroid Nodule trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.